Literature DB >> 14705820

Esophagitis impairs esophageal smooth muscle reactivity in the rat model: an in vitro study.

Melih Tugay1, Firuzan Yildiz, Tijen Utkan, Bahar Müezzinoğlu, Faruk Erden, Nejat Gacar, Güner Ulak.   

Abstract

The present study investigated how reflux-induced esophagitis affects the smooth muscle reactivity of the esophageal body. Two different esophagitis models were used: acid gastric and mixed duodenogastric reflux. All test animals apart from the controls developed gross and histologic evidence of esophagitis. Contractile (carbachol and KCI) and relaxant (isoproterenol) esophageal smooth muscle responses were significantly decreased in the presence of acid- and mixed reflux-induced esophagitis. Similar relaxant responses to serotonin and papaverine were found in the three groups. Our study demonstrated impaired esophageal smooth muscle reactivity when esophagitis was induced by acid or mixed reflux. These changes may correspond to the functional motor abnormalities of the esophagus seen in patients with reflux esophagitis.

Entities:  

Mesh:

Year:  2003        PMID: 14705820     DOI: 10.1023/b:ddas.0000004518.98825.6c

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Does the duration of gastroesophageal reflux disease and degree of acid reflux correlate with esophageal function? A retrospective analysis of 768 patients.

Authors:  Y Shiino; C J Filipi; T Tomonaga; Z T Awad; R E Marsh
Journal:  J Clin Gastroenterol       Date:  2000-01       Impact factor: 3.062

Review 2.  Clinical relevance of gastroduodenal dysfunction in reflux esophagitis.

Authors:  A Dubois
Journal:  J Clin Gastroenterol       Date:  1986       Impact factor: 3.062

3.  Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present.

Authors:  P Singh; R H Taylor; D G Colin-Jones
Journal:  Am J Gastroenterol       Date:  1994-03       Impact factor: 10.864

4.  Oesophagitis and pH of refluxate: an experimental and clinical study.

Authors:  G Zaninotto; F Di Mario; M Costantini; R Baffa; B Germanà; P L Dal Santo; M Rugge; M Bolzan; R Naccarato; E Ancona
Journal:  Br J Surg       Date:  1992-02       Impact factor: 6.939

5.  Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux.

Authors:  H J Stein; A P Barlow; T R DeMeester; R A Hinder
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

6.  Alterations of gut neuropeptides in gastroesophageal reflux disease are resolved after antireflux surgery.

Authors:  M Gadenstätter; R Prommegger; A Klingler; H Schwelberger; H G Weiss; K Glaser; G J Wetscher
Journal:  Am J Surg       Date:  2000-12       Impact factor: 2.565

7.  Healing of severe esophagitis improves esophageal peristaltic dysfunction.

Authors:  P Deprez; R Fiasse
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

8.  Pharmacological properties of mechanical responses of the rat oesophageal muscularis mucosae to vagal and field stimulation.

Authors:  D Bieger; C Triggle
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

9.  The effect of healing oesophagitis on oesophageal motor function as determined by oesophageal scintigraphy and ambulatory oesophageal motility/pH monitoring.

Authors:  N I McDougall; R B Mooney; W R Ferguson; J S Collins; R J McFarland; A H Love
Journal:  Aliment Pharmacol Ther       Date:  1998-09       Impact factor: 8.171

10.  Esophagitis in Sprague-Dawley rats is mediated by free radicals.

Authors:  G J Wetscher; G Perdikis; D H Kretchmar; R G Stinson; D Bagchi; E J Redmond; T E Adrian; R A Hinder
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

View more
  1 in total

1.  The role of the 5-hydroxytryptamine pathway in reflux-induced esophageal mucosal injury in rats.

Authors:  Lingrong Yang; Haifang Cai; Jinfa Tou; Weizhong Gu; Xiaoli Shu; Ting Zhang; Xi Yang; Zheng Shen; Mizu Jiang
Journal:  World J Surg Oncol       Date:  2012-10-23       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.